250+ investors that invest in your industry and stage Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Finance
Retail
Infrastructure
Non Profit
Oil and Gas
Fashion
Theatre
Renewable Energy
Sporting Goods
Celebrity
Social Impact
Restaurants
Cryptocurrency
SaaS
Machine Learning
Agriculture (AgTech)
Media (Entertainment)
Blockchain
Facebook
Publishing
Beauty
Real Estate
Life Science
B2B
Film
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Food and Beverage
Social Network
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Nigeria
Jamaica
Honduras
Isle of Man
Finland
Mozambique
Luxembourg
Albania
Pakistan
Algeria
Romania
Bangladesh
Kenya
Kazakhstan
Cayman Islands
Cambodia
Oman
Ireland
Cameroon
Colombia
Guatemala
Seychelles
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
New Zealand
United States
Cyprus
India
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Find investors

Top 50 Biotechnology VC Funds & Investors in Asia (June 2026)

The most active venture capital funds investing in Asia Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Qiming Venture Partners
VC Fund
58 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$142M
HSG
VC Fund
43 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $4.4M–$214M
BioVenture
VC Fund
33 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.6M–$73M
Lilly Asia Ventures
VC Fund
30 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$259M
Med-Fine Capital
VC Fund
28 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $2.8M–$60M
Kaitai Capital
VC Fund
26 China, United States, Singapore Series A, Series B, Angel Biotechnology, Health Care, Pharmaceutical $425k–$57M
Frees Fund
VC Fund
25 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Health Care, Biotechnology $425k–$35M
Matrix Partners China
VC Fund
25 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $2.8M–$200M
IDG Capital
VC Fund
22 China, United States, India Series A, Series B, Series C Software, Internet, E-Commerce $3M–$190M
Sherpa Healthcare Partners
VC Fund
22 China, United States, Kenya Series A, Series B, Series C Biotechnology, Health Care, Medical $2.8M–$156M
Seeds Capital
VC Fund
21 Singapore, United States, Hong Kong Seed, Series A, Series B Software, Biotechnology, Health Care $767k–$45M
Legend Capital
VC Fund
19 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.8M–$200M
Northern Light Venture Capital
VC Fund
19 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $1.3M–$100M
TF Capital
VC Fund
18 China, United States Series A, Series B Biotechnology, Health Care, Medical $5.7M–$120M
CDH Investments
VC Fund
18 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $8.3M–$300M
Mitsubishi UFJ Capital
VC Fund
18 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $2M–$397M
Hillhouse Investment
VC Fund
18 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
UntroD Capital
VC Fund
18 Japan, Singapore, Austria Seed, Series A Manufacturing, Biotechnology, Medical $2M–$241M
Fast Track Initiative, Inc.
VC Fund
16 Japan, United States, United Kingdom Series A, Seed, Series B Health Care, Biotechnology, Medical $1.1M–$184M
Highlight Capital
VC Fund
16 China, United States, Portugal Series A, Series B, Seed Health Care, Medical, Biotechnology $2.8M–$84M
Linear Capital
VC Fund
16 China, Singapore, Switzerland Seed, Angel, Series A Artificial Intelligence, Software, Manufacturing $1.4M–$122M
CD Capital
VC Fund
15 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Osaka University Venture Capital
VC Fund
15 Japan Seed, Series A Biotechnology, Health Care, Manufacturing $7.1M–$142M
ANRI
VC Fund
15 Japan, United States, India Seed, Series A Software, Health Care, Information Technology $1M–$624M
Puhua Capital
VC Fund
15 China, United Kingdom, United States Series A, Series B, Seed Health Care, Medical, Manufacturing $1.4M–$112M
Delian Capital
VC Fund
15 China, United States, France Series A, Seed, Series B Biotechnology, Manufacturing, Health Care $199k–$50M
Baidu Ventures
VC Fund
14 China, United States, Singapore Series A, Seed, Series B Artificial Intelligence, Health Care, Biotechnology $1.4M–$145M
Prox Ventures
VC Fund
14 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Cowin Capital
VC Fund
14 China, Hong Kong, United States Series A, Series B, Seed Manufacturing, Health Care, Biotechnology $1.4M–$50M
SMBC Venture Capital
VC Fund
14 Japan, United States, Singapore Series A, Series B Information Technology, Health Care, Software $5M–$425M
Green Pine Capital Partners
VC Fund
14 China, United States, Canada Series A, Series B, Angel Biotechnology, Software, Manufacturing $425k–$150M
Gaorong Capital
VC Fund
14 China, United States, Hong Kong Series A, Series B, Seed Information Technology, Software, Artificial Intelligence $2.8M–$110M
SDIC Venture Capital
VC Fund
13 China, United States, Hong Kong Series B, Series A, Series C Manufacturing, Biotechnology, Electronics $2.8M–$170M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
13 Japan, United States, India Seed, Series A Health Care, Biotechnology, Medical $3.1M–$85M
BioTrack Capital
VC Fund
13 China, United States, Singapore Series A, Series B, Seed Biotechnology, Health Care, Medical $3M–$168M
K2VC
VC Fund
12 China, United States, Japan Series A, Seed, Angel E-Commerce, Manufacturing, Biotechnology $425k–$24M
Legend Star
VC Fund
12 China, United States, France Series A, Seed, Angel Health Care, Medical, Biotechnology $425k–$50M
Cowin Venture
VC Fund
12 China, United States, Hong Kong Series A, Angel, Series B Health Care, Medical, Biotechnology $425k–$257M
Shenzhen Capital Group
VC Fund
12 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Software $1.4M–$142M
Keio Innovation Initiative
VC Fund
12 Japan, United Kingdom Series A, Seed Health Care, Medical, Biotechnology $1.5M–$400M
Pan-Lin Capital
VC Fund
11 China, United States, Canada Series A, Seed, Series B Health Care, Biotechnology, Medical $1k–$57M
ZhenFund
VC Fund
11 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Software, E-Commerce $413k–$28M
LYFE Capital
VC Fund
11 China, United States, France Series B, Series A, Series C Biotechnology, Health Care, Medical $6.5M–$148M
Addor Capital
VC Fund
11 China, Hong Kong, Singapore Series A, Series B Manufacturing, Semiconductor, Electronics $1.4M–$43M
JAFCO
VC Fund
11 Japan, United States, Israel Series A, Series B Information Technology, Software, Artificial Intelligence $2.7M–$425M
Hillhouse Ventures
VC Fund
11 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care $10M–$120M
Shunwei Capital
VC Fund
11 China, United States, India Series A, Series B, Series C Manufacturing, Software, Internet $1.4M–$130M
Oriental Fortune Capital
VC Fund
11 China, United States Series A, Series B, Seed Software, Manufacturing, Information Technology $1.4M–$100M
Sinovation Ventures
VC Fund
10 China, United States, Singapore Series A, Seed, Series B Software, Artificial Intelligence, Internet
ARCH Venture Partners
VC Fund
10 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.8M–$230M
Access all 50 VC funds in Asia Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 58 investments in Asia Biotechnology startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 716
  • Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Fitlens — Fitlens
  • Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
  • Woof — Woof is a street fashion community and e-commerce platform for young generations.
Show all investments...

HSG
VC Fund · Beijing, Beijing, China · 43 investments in Asia Biotechnology startups, 10 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 751
  • Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 33 investments in Asia Biotechnology startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 152
  • Round size: Seed $1.6M–$20M; Series A $1.9M–$42M; Series B $3M–$73M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • MacroLux — MacroLux Medical Technology Co., Ltd.
  • Ubiquitin Bio — Ubiquitin Bio is a research and development manufacturer of in vitro diagnostic products.
  • Yulu Qianxing — Yulu Qianxing is an AI-powered platform that focuses on quantum mechanics, and molecular simulation algorithms to enable novel drug research and development by simulating processes.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 30 investments in Asia Biotechnology startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 209
  • Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Langlai Technology — Langlai Technology is a clinical-stage innovative drug research and development company. Adhering to the dual-drive strategy of synchronously improving the R&D pipeline and platform construction, it has built a full-process new drug R&D process from concept verification, candidate compound screening, preclinical druggability development toclinical research. system.
  • Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 28 investments in Asia Biotechnology startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 75
  • Round size: Seed $8M–$21M; Series A $2.8M–$40M; Series B $11M–$60M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $69M in 2019

Portfolio highlights

  • Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
  • Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
  • Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Show all investments...

Kaitai Capital
VC Fund · Hangzhou, Zhejiang, China · 26 investments in Asia Biotechnology startups

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 122
  • Round size: Angel $425k–$14M; Series A $1.4M–$35M; Series B $4.3M–$57M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
  • Primelink Bio — Primelink Bio is a Biotechnology firm that is working to to develop next generation of drug delivery systems.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 25 investments in Asia Biotechnology startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 194
  • Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
  • Jiajin Biotech — Jiajin Biotech is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 25 investments in Asia Biotechnology startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 432
  • Round size: Series A $2.8M–$60M; Series B $9.5M–$113M; Series C $14M–$200M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Ouli Biomedical — Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration.
  • Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 22 investments in Asia Biotechnology startups

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 705
  • Round size: Series A $3M–$112M; Series B $7.4M–$142M; Series C $14M–$190M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Polymaker — Polymaker is a high quality 3D printing filament manufacturers. PLA, PETG, ABS, ASA, TPU, Nylon, PC, Carbon Fiber and more. Find the best filament for your application.
  • Ripple — Discover why hundreds of financial institutions choose Ripple to provide a better international payments experience for their customers in real-time.
  • Singularity Energy Technology — Singularity Energy is committed to core technology research and product development in advanced energy storage systems, and contributes industry-leading solutions to promote large-scale clean energy integration and achieve global carbon neutrality goals.
Show all investments...

Sherpa Healthcare Partners
VC Fund · Beijing, Beijing, China · 22 investments in Asia Biotechnology startups

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Kenya

Investor stats

  • Total investments: 97
  • Round size: Series A $2.8M–$43M; Series B $14M–$100M; Series C $12M–$156M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
  • Yosemite Clinic — Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitationmedicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
  • Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 21 investments in Asia Biotechnology startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 121
  • Round size: Seed $767k–$5.2M; Series A $3.5M–$24M; Series B $5M–$45M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Datakrew — Datakrew delivers real-time EV battery analytics and AI-powered fleet intelligence. Smarter, safer fleets start here. Explore our solutions.
  • Atomionics — Atomionics is building atomic sensors for navigation and resource exploration. Sensing technology is severely inadequate for a lot of applications navigation and positioning, pinpointing oil and gas reserves, tunnel detection etc. Atomionics builds atomic sensors harnessing quantum mechanical properties of the atoms. This enables measurement ofparameters like gravity, acceleration and rotation with 1000x higher precision and accuracy than the current state of the art, leading to a completely new way of global positioning, and resource exploration.
  • Brano Therapeutics — Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 19 investments in Asia Biotechnology startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 372
  • Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Dipeak — Dipeak is a big data computing and artificial intelligence company that helps businesses traverse the AI era. Dipeak offers computer software services connected to data intelligence engines that integrate computing intelligence.
  • Bespin Global — Bespin Global provides consulting, migration, managed services, and solutions for hybrid cloud. They rapidly implement architectures optimized for various industry areas into a hybrid cloud environment interacting with IDB using AWS, MS Azure, and Flexcloud. Bespin Global is a premium brand for strengthening Hostway's cloud business that hasprovided corporate professional hosting services and managed services since 1998 and is dedicated to Hostway's cloud managed service provider (MSP) business.
  • Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 19 investments in Asia Biotechnology startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 236
  • Round size: Seed $1.3M–$100M; Series A $4.3M–$40M; Series B $11M–$62M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
  • RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
  • Spiro Medical — Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.
Show all investments...

TF Capital
VC Fund · Pudong, Shandong, China · 18 investments in Asia Biotechnology startups

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 61
  • Round size: Series A $5.7M–$120M; Series B $11M–$110M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Vybio — Vybio focuses on the research and development of new drugs for oncology and hepatitis B. The core members of the team have 30 years of experience in tumor and hepatitis B drug research and development, and come from well-known pharmaceutical companies such as WuXi AppTec, Pfizer, BMS, etc., using a specific tumor microenvironment to independentlyinnovate prodrug design and screening, and developed a series of global drugs. Preclinical research on precisely targeted small molecule anticancer prodrug compounds protected by intellectual property rights is being carried out in an orderly manner.
  • QL Biopharma — QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
  • Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
Show all investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 18 investments in Asia Biotechnology startups

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 261
  • Round size: Series A $8.3M–$198M; Series B $14M–$142M; Series C $14M–$300M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • ZSPepLib — Zonsen PepLib Biotech Inc. Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
  • Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
  • Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 18 investments in Asia Biotechnology startups

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 462
  • Round size: Series A $2M–$113M; Series B $6.4M–$397M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • Sotas — Sotas provides services to chemical trading companies and bridges the gap between raw material producers and consumers.
  • PartnerProp — PartnerProp is a PRM tool with outstanding potential and a wide variety of capabilities that resolves all partner business difficulties.
  • Infobox — Infobox is a sales data platform that includes every detail from market research to creating a list of companies and contacting decision-makers.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 18 investments in Asia Biotechnology startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

UntroD Capital
VC Fund · Sumida, Tokyo, Japan · 18 investments in Asia Biotechnology startups

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 119
  • Round size: Seed $2M–$43M; Series A $2.1M–$241M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
  • Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
  • Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Show all investments...

Fast Track Initiative, Inc.
VC Fund · Hongo, Tokyo, Japan · 16 investments in Asia Biotechnology startups

Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 73
  • Round size: Seed $1.2M–$117M; Series A $1.1M–$142M; Series B $7.7M–$184M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2021

Portfolio highlights

  • NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
  • Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 16 investments in Asia Biotechnology startups, 23 in the past 12 months

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Portugal

Investor stats

  • Total investments: 140
  • Round size: Seed $8.5M–$84M; Series A $2.8M–$73M; Series B $7.6M–$70M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Yixiu — Yixiu provides sleep health products such as smart wearables, smart home sleep scene hardware, sleep data analysis platforms, energy management apps, and more.
  • Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
  • PoShell Robotics — PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Linear Capital
VC Fund · Shanghai, Shanghai, China · 16 investments in Asia Biotechnology startups

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Manufacturing
  • Stage:Seed, Angel, Series A
  • Geography: China, Singapore, Switzerland

Investor stats

  • Total investments: 85
  • Round size: Seed $1.4M–$120M; Angel $1.4M–$122M; Series A $5.7M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
  • Juehua Medical — Juehua Medical is a medical technology company focusing on the field of visual health.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 15 investments in Asia Biotechnology startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$14M; Series A $1.4M–$27M; Series B $7.1M–$34M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Pipi Bear
  • Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 15 investments in Asia Biotechnology startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 75
  • Round size: Seed $7.1M–$99M; Series A $18M–$142M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Ayumo — Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.
  • QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
  • Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Show all investments...

ANRI
VC Fund · Tokyo, Tokyo, Japan · 15 investments in Asia Biotechnology startups

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 235
  • Round size: Seed $1M–$94M; Series A $6.1M–$624M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $102M in 2022

Portfolio highlights

  • Fondi — fondi is a completely new English conversation communication service that allows you to live a virtual communal life with the world.
  • Taian — Taian, which specializes in bridal industry services and software. They also provide ''Concept Marry,'' which allows couples to design invites and seating charts that match their wedding theme, as well as display guest information on Oiwaii.
  • Knowledge Work — Knowledge Work specializes in the development and sales of software for companies.
Show all investments...

Puhua Capital
VC Fund · Hangzhou, Zhejiang, China · 15 investments in Asia Biotechnology startups

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Show more...

Investment focus

  • Industry: Health Care, Medical, Manufacturing
  • Stage:Series A, Series B, Seed
  • Geography: China, United Kingdom, United States

Investor stats

  • Total investments: 177
  • Round size: Seed $1.4M–$29M; Series A $1.4M–$112M; Series B $2.8M–$100M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Lc Space
  • TCab Tech — TCab Tech is building a air mobility ecosystem in order to provide the general public with zero-emission airborne ridesharing.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
Show all investments...

Delian Capital
VC Fund · Beijing, Beijing, China · 15 investments in Asia Biotechnology startups, 8 in the past 12 months

Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, France

Investor stats

  • Total investments: 90
  • Round size: Seed $199k–$50M; Series A $1.6M–$17M; Series B $9.9M–$29M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Rigerna — Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
  • MingShi Brain-Computer Interaction — Mindtrix (明视脑机) develops brain–computer‑interface technology focused on reconstructing visual information and neural signals from the brain, primarily for visual‑reconstruction and implantable‑BCI applications. It conducts research and builds systems to decode brain‑wave patterns and translate them into machine‑interpretable outputs, aiming atadvanced neurotechnology and human–machine interfaces. The company also works on underlying hardware and software platforms that support high‑precision neural data acquisition, processing, and real‑time feedback loops.
Show all investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 14 investments in Asia Biotechnology startups

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 200
  • Round size: Seed $1.9M–$14M; Series A $1.4M–$42M; Series B $8M–$145M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Zeabur — A platform that help you deploy your service with one click, No matter what programming language you use, what framework you use.
  • Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
  • Automation Hero — Reduce your company's document processing time with an intelligent automation platform that's simple, secure, and accurate.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 14 investments in Asia Biotechnology startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 14 investments in Asia Biotechnology startups

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 264
  • Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2014

Portfolio highlights

  • HUAUN — HUAUN is a security vendor that focuses on vulnerability management and AI offense and defense.
  • Sinsegye — Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier.
  • Digital China — Digital China is a robotics company focused on developing humanoid interactive robots that can break traditional boundaries and create emotionally resonated partners.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 14 investments in Asia Biotechnology startups

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Industry: Information Technology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 485
  • Round size: Series A $5M–$170M; Series B $7.4M–$425M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
  • Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
  • Okuma Diamond Device — Ookuma Diamond Device Co., Ltd. | Creating a next-generation semiconductor industry from Japan, driven by the mission to support the decommissioning of Fukushima Daiichi Nuclear Power Plant.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 14 investments in Asia Biotechnology startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Manufacturing
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 166
  • Round size: Angel $425k–$2.9M; Series A $1.4M–$100M; Series B $4M–$150M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $138M in 2019

Portfolio highlights

  • MindRank AI — MindRank AI is a developer of proprietary end-to-end AI-driven drug discovery platform (Molecule Pro™).
  • Ruitai Biotechnology — Ruitai is a developer for ophthalmic regenerative medicine, specialising in the R&D and sale of repair materials and medical device products
  • Signet Therapeutics — Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.
Show all investments...

Gaorong Capital
VC Fund · Wangjing, Beijing, China · 14 investments in Asia Biotechnology startups

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 257
  • Round size: Seed $2.8M–$57M; Series A $2.8M–$73M; Series B $14M–$110M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2020

Portfolio highlights

  • PDD Holdings — Pinduoduo is an e-commerce platform allowing users to participate in group buying deals, mostly through Tencent’s Wechat app. The company was founded in 2015 and is based in Shanghai, China.
  • Linton Automobile — Linton Automobile is a manufacturer of automotive accessories and parts.c
  • Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
Show all investments...

SDIC Venture Capital
VC Fund · Xicheng, Hebei, China · 13 investments in Asia Biotechnology startups

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Electronics
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 148
  • Round size: Series A $8.5M–$99M; Series B $2.8M–$170M; Series C $14M–$75M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Parylene — Parylene is a provider of protective coating application solutions
  • Yanshengchao — Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China
  • Alnan Aluminium — Alnan Aluminium is an industrial company that offers aluminum products, fabrication, and non-ferrous metal smelting services.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 13 investments in Asia Biotechnology startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 172
  • Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ALGO ARTIS — ALGO ARTIS is a software company that offers optimization in plant operations, tanking, ship allocation plan, and logistics.
  • SUN METALON — SUN METALON aims to create a world where metal products can be produced from local ores. The company was founded in 2021 and is headquartered in Redondo Beach, California.
  • BUGWORKS Research — Bugworks, a clinical stage biopharmaceutical company Harnessing the power of science to develop affordable, accessible, novel therapies against infectious disea
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 13 investments in Asia Biotechnology startups

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 84
  • Round size: Seed $14M–$168M; Series A $3M–$43M; Series B $14M–$150M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
  • Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Show all investments...

K2VC
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotechnology startups

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Show more...

Investment focus

  • Industry: E-Commerce, Manufacturing, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 177
  • Round size: Seed $1M–$14M; Angel $425k–$10M; Series A $1.4M–$24M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $141M in 2018

Portfolio highlights

  • Zhicheng Power — Zhicheng Power is a fully automatic life service provider that specializes in the research, development, and manufacturing of household intelligence robots and other smart equipment, offering one-stop fully automatic life service solutions to all consumer families.
  • Tongwei New Energy — Tongwei New Energy is a company that manufactures zero-carbon solid oxide fuel cells. Its major product is distributed zero-carbon power plants.
  • Zhongling Xingneng — Zhongling Xingneng provides green energy services. It focuses on household photovoltaics and the topic of distributed photovoltaics. It delivers solutions for the whole life cycle of rooftop photovoltaic power plants, including investment, consultancy, design, building, operation, and maintenance, to residents and industrial and commercialcompanies. New energy ecological sectors, such as energy storage and wind power, will be developed in the future.
Show all investments...

Legend Star
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotechnology startups

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, France

Investor stats

  • Total investments: 134
  • Round size: Seed $1.4M–$19M; Angel $425k–$7.1M; Series A $1.4M–$50M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $109M in 2018

Portfolio highlights

  • VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
  • Zhizai Wujie — Zhizai Wujie is a robotics company that specializes in research, development, and application of humanoid robots.
  • Booster Robotics — Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items.
Show all investments...

Cowin Venture
VC Fund · Beijing, Beijing, China · 12 investments in Asia Biotechnology startups

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 92
  • Round size: Angel $425k–$1.4M; Series A $1.4M–$25M; Series B $2.8M–$257M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Meraki — Meraki is dedicated to serving the European and American markets with a curated range of products designed specifically for home coffee lovers. With a deep understanding of regional preferences and a passion for quality.
  • Amador Bioscience — At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
  • Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 12 investments in Asia Biotechnology startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 368
  • Round size: Series A $1.4M–$142M; Series B $13M–$142M; Series C $4.3M–$142M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ATAPEX — ATAPEX aims to break the domestic mass production gap of ultra-precision metal sheet processing. Its product business covers Display panel, display terminal, VR/AR display, including Divide Open Mask for AMOLED, Divide Fine Metal Mask, Micro OLED Open Mask for silicon-based OLED, metal support sheet for display terminal and other high-endultra-fine processing products, connected in series A related industry chain to help customers solve various problems such as less choice of related products, unstable quality, long delivery time etc.
  • Tauren — Tauren is a domestic and hybrid design enterprise of analog and analog-digital chips. At present, the company has won the recognition of the top first-line customers and the strong support of the first-line investment institutions; in the future, it will continue to cultivate the analog and analog-digital hybrid design track, and provide highlycompetitive standardized products for the market landing demand. Provide customers with stable and first-class quality semiconductor products.
  • LinearX — Lingnian Technology is a software company that provides mass-production-level operating systems for intelligent driving vehicles. It has created high-security, high-real-time in-vehicle middle-layer platform software. Lingnian uses self-developed dual-communication middleware to achieve reliable data transmission of heterogeneous chips.
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 12 investments in Asia Biotechnology startups

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: Japan, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $1.5M–$213M; Series A $2.3M–$400M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
  • Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
  • Nanofiber Quantum Technologies — Discover how NanoQT builds the foundation for scalable quantum computing with nanofiber cavity-QED technology and high-fidelity quantum connectivity.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pan-Lin Capital
VC Fund · Shanghai, Shanghai, China · 11 investments in Asia Biotechnology startups

Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 70
  • Round size: Seed $1k–$28M; Series A $1.4M–$35M; Series B $2.8M–$57M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Libo Biotech — Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA.
  • Lingdong Core Optics — Lingdong Core Optics is a high-tech firm that specializes in the design and implementation of silicon-based integrated optoelectronic chips.
  • Suzhou Ribo Life Science — Established in 2007, Suzhou Ribo Life Science Co. Ltd. is devoted to the advanced oligonucleotide therapeutics in China including siRNA, antisense and aptamer drugs based on proprietary intellectual properties.
Show all investments...

ZhenFund
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotechnology startups

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, E-Commerce
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 357
  • Round size: Seed $413k–$20M; Angel $425k–$5.7M; Series A $1.4M–$28M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $130M in 2022

Portfolio highlights

  • ChatCut — ChatCut lets you edit videos using natural language. Remove repeated takes, restructure content, and cut down for social media with simple prompts. Perfect for interviews and documentaries.
  • Pingxin Technology — Pingxin Technology aims to transform and accelerate the advancement of AI computing by fully integrating data storage and computing into a combined chip architecture, cutting costs and improving efficiency.
  • Xiangke Intelligence — Tsinghua University, Beijing University of Aeronautics and Astronautics, computer and robotics professionals, and industrial serial entrepreneurs founded Xiangke Intelligence. It was established by the former founder of "Speed Technology" and the general manager of SharkNinja China Robot R&D Centre.
Show all investments...

LYFE Capital
VC Fund · Shanghai, Shanghai, China · 11 investments in Asia Biotechnology startups

LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, France

Investor stats

  • Total investments: 79
  • Round size: Series A $11M–$85M; Series B $15M–$148M; Series C $6.5M–$142M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
  • Starna Therapeutics — Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
  • ALLYRNA Pharmaceuticals — ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers.
Show all investments...

Addor Capital
VC Fund · Nanjing, Jiangsu, China · 11 investments in Asia Biotechnology startups

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Electronics
  • Stage:Series A, Series B
  • Geography: China, Hong Kong, Singapore

Investor stats

  • Total investments: 270
  • Round size: Series A $1.4M–$28M; Series B $11M–$43M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Heguang New Energy — Heguang New Energy is China's largest producer of square silicon cores for polysilicon and has long-term and stable purchase agreements with a number of major polysilicon producers.
  • Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
  • Nanzhi Core Material — Nanzhi Core Material is a research and development manufacturer of optical grade lithium niobate crystal.
Show all investments...

JAFCO
VC Fund · Tokyo, Tokyo, Japan · 11 investments in Asia Biotechnology startups

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: Japan, United States, Israel

Investor stats

  • Total investments: 252
  • Round size: Series A $2.7M–$255M; Series B $8.3M–$425M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Caguuu — Caguuu offers high-quality designer furniture at affordable prices, through e-commerce, eliminating middlemen and store operating costs.
  • QREATION — QREATION is a digital intellectual property studio specializing in producing a wide range of popular content that originates primarily from social media platforms. The company focuses on creating high-quality short-form entertainment, including short dramas, comedy sketches, and variety shows.
  • ARCS — ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 11 investments in Asia Biotechnology startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 71
  • Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
  • Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
  • HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 11 investments in Asia Biotechnology startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Internet
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 408
  • Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
  • Darma — DARMA - Digital Healt
  • LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 11 investments in Asia Biotechnology startups

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 217
  • Round size: Seed $2.8M–$74M; Series A $1.4M–$30M; Series B $2.9M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
  • Technological Innovation — Technological Innovation is a provider of brain-computer interface (BCI) technology research and development, as well as application services.
  • Photoacoustic Pharmaceuticals — Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy.
Show all investments...

Sinovation Ventures
VC Fund · Beijing, Beijing, China · 10 investments in Asia Biotechnology startups

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 245
  • Lead/follow: no public data

Portfolio highlights

  • BasePoint Origin — BasePoint Origin is a high-tech company focused on developing an AI operating system that automatically characterizes enterprise business processes. This system replaces traditional manual methods—such as expert visits, data collection, and modeling—with AI, greatly enhancing the efficiency and accuracy of optimizing business processes.
  • Lanzhou Technology — Lanzhou Technology is a cognitive intelligence company that provides business insights products.
  • Zongwei Automation — Shanghai Zongwei Automation Co., Ltd. (ZONGWEI) is a research and development enterprise focusing on automation flexibility technology and solutions. The company has leading linear motion control core technology and experience, and independently developed key supporting equipment such as controllers, driver series and feedback systems dedicated tolinear motion. High-performance products and super-optimal solutions have been widely used in semiconductors, new energy, high-end daily chemicals, 3C electronics and other fields, improving delivery efficiency and reducing production costs for many world-class industrial giants and listed company customers.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 10 investments in Asia Biotechnology startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 377
  • Round size: Series A $7.8M–$200M; Series B $13M–$230M; Series C $15M–$175M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Metsera — Metsera operates as a clinical-stage biopharmaceutical company.
  • EGenesis — At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
  • Protillion Biosciences — Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Asia Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists